An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
Top results in this bookTable of Contents
Ustekinumab (Stelara) Injection [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov.
Apremilast (Otezla) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Sep.
Clinical Review Report: Ixekizumab (Taltz): (Eli Lilly Canada Inc.): Indication: Treatment of adult patients with active psoriatic arthritis who have responded inadequately to, or are intolerant to one or more disease-modifying antirheumatic drugs (DMARD). Taltz can be used alone or in combination with a conventional DMARD (e.g., methotrexate) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Aug.
Etanercept, Infliximab and Adalimumab for the Treatment of Psoriatic Arthritis: A Systematic Review and Economic Evaluation.
Rodgers M, Epstein D, Bojke L, et al.
Southampton (UK): NIHR Journals Library; 2011 Feb. (Health Technology Assessment, No. 15.10.)
Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation.
Corbett M, Chehadah F, Biswas M, et al.
Southampton (UK): NIHR Journals Library; 2017 Oct. (Health Technology Assessment, No. 21.56.)
Guselkumab (Tremfya): CADTH Reimbursement Review: Therapeutic Area: Psoriatic arthritis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Feb.
Skills in Rheumatology [Internet].
Almoallim H, Cheikh M, editors.
Singapore: Springer; 2021.
Pharmacoeconomic Review Report: Ixekizumab (Taltz): (Eli Lilly Canada Inc.): Indication: Treatment of adult patients with active psoriatic arthritis who have responded inadequately to, or are intolerant to one or more disease-modifying antirheumatic drugs (DMARD). Taltz can be used alone or in combination with a conventional DMARD (e.g., methotrexate) [Internet].
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Adverse Effects of Vaccines: Evidence and Causality.
Committee to Review Adverse Effects of Vaccines; Institute of Medicine; Stratton K, Ford A, Rusch E, et al., editors.
Washington (DC): National Academies Press (US); 2011 Aug 25.
Bimekizumab (Bimzelx): Therapeutic area: Psoriatic arthritis: CADTH Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Sep.
Mother To Baby | Fact Sheets [Internet].
Brentwood (TN): Organization of Teratology Information Specialists (OTIS); 1994-.
Clinical Review Report: Tildrakizumab (Ilumya): (Sun Pharma Global FZE): Indication: For the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021 Aug.
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation.
Duarte A, Mebrahtu T, Goncalves PS, et al.
Southampton (UK): NIHR Journals Library; 2017 Nov. (Health Technology Assessment, No. 21.64.)
Selected Immune Disorders and Disability.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Committee on Selected Immune Disorders and Disability.
Washington (DC): National Academies Press (US); 2022 May 24.
Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Interim Progress and Surveillance Reports [Internet].
Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Dec-.
Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study.
Jones AP, Clayton D, Nkhoma G, et al.
Southampton (UK): NIHR Journals Library; 2020 Jul. (Health Technology Assessment, No. 24.36.)
Clinical Review Report: Certolizumab Pegol (Cimzia): (UCB Canada Inc.): Indication: Treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Jan.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on